We appreciate your thoughtful response to our recent manuscript on pulmonary complications after elective liver transplantation (1). We would like to begin with a few general comments and then address your specific queries individually. The diagnosis of pneumonia is challenging for physicians who care for critically ill patients. In the setting of liver transplantation with immunocompromised patients, underestimating the probability of pneumonia can lead to increased mortality. For us, these patients should be treated aggressively to diminish the morbidity and mortality associated with these complications. Conversely, overestimated probability of pneumonia can lead to inappropriate antibiotic use with emergence of multiresistant organisms in patients with many hospitalizations. Consistent with previous studies in critical care and, in particular, the study recently published by Weiss et al. (2), in the liver transplantation context, we choose a combined criteria, widely accepted (3), to retain the diagnosis of pneumonia in patients admitted in the intensive care unit after liver transplantation. In practice, in patients with several criteria of pneumonia and a microorganism identified, the diagnosis of pneumonia has been retained (n=39). In the situation where no microorganism has been isolated (because the samples were not feasible because of the severity of patients or because the results were negative), the calculation of the modified clinical pulmonary infection score allowed a positive confirmation of the diagnosis of pneumonia (n=16). In this subgroup of our cohort, the modified clinical pulmonary infection score value is 7 (5–9). Among the 55 episodes of pneumonia, the rate of ventilator-associated pneumonia was 49% (27/55). In our cohort, no patient was still on antibiotics prophylaxis (piperacillin for the first 48 hr) when the diagnosis of pneumonia was retained. However, in three patients, where a diagnosis of late pulmonary infection (>6 days) was made, the patients were already on antibiotics. In these three cases, a new microorganism (Pseudomonas) had been isolated resistant to the previous antibiotic treatment. Although there is a lack of information in the data provided by Hong et al. (4) (only 7 patients with infectious complications after liver transplantation in their article), it may be interesting to know whether there is a correlation between the infection, the acute cellular rejection, and the immunosuppressive regimen. The aim of our study was to identify risk factors for pulmonary complications among preoperative and intraoperative variables. We did not seek to find the associated factors of pneumonia. However, in our cohort, we have diagnosed 27 patients with a history of acute cellular rejection (confirmed by a liver histology with the Banff internationally accepted criteria [5]). No significant difference has been found between patients who developed pneumonia and those who did not (4 [8.5%] in patients with pneumonia and 23 [13.9%] in patients without pneumonia, P=0.45). The same reasoning can be held for patients with renal dysfunction, and no association between dialysis and pneumonia has been observed. We thank the readers for their comment about the age of recipients: an error has crept into the text. Indeed, patients who developed pneumonia were older in the univariate analysis (P=0.036). In the logistic regression analysis, the age was not an independent risk factor of pneumonia. For the study, we did not modify the practice in the preoperative management of ascites and pleural effusions, including the period before performing the pulmonary function tests. Our results require us to question the preoperative management of patients awaiting transplantation (for example, with a systematic preoperative pleural evacuation). Finally, we agree with the readers that the pleural effusion is present from the immediate postoperative period. We choose to quantify the postoperative pleural effusion on the seventh day by a computed tomographic scan to homogenize the measures. In practice, we evaluate the pleural effusion by bedside chest x-ray and ultrasound 7 days before, and when the pleural effusion is abundant or associated with respiratory failure, a percutaneous pleural drainage is performed. In our experience, most patients have, after liver transplantation, an early effusion that resolves within weeks. Thank you again for your interest in our study. Eric Levesque 1 Didier Samuel1,2,3 1Assistance Publique des Hôpitaux de Paris Hôpitaux Paul Brousse Centre Hépato-Biliaire Villejuif, France 2 Université Paris-Sud Unité mixte de recherche UMR-S785 Villejuif, France 3 Inserm, Unité 785, Villejuif, France
Read full abstract